Disease phenotyping using the swings of disease

U. Frey (Basel, Switzerland)

Source: Annual Congress 2011 - New dimensions in respiratory clinics - Peter Macklem memorial symposium
Session: New dimensions in respiratory clinics - Peter Macklem memorial symposium
Session type: Hot topics
Number: 3182

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
U. Frey (Basel, Switzerland). Disease phenotyping using the swings of disease. Annual Congress 2011 - New dimensions in respiratory clinics - Peter Macklem memorial symposium

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Disease progression patterns in COPD
Source: International Congress 2018 – New predictors of morbidity and mortality in COPD
Year: 2018


Disease pathology in interstitial lung disease
Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options
Year: 2021


Prevalence of Anxiety Disorders and Depression in Patients with Chronic Obstructive Pulmonary Disease and correlation with the clinical stage of the disease
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021


Evaluation of the respiratory function in a population with mild/moderate Parkinson's disease
Source: International Congress 2014 – Sleep disordered breathing 5
Year: 2014

Disease severity in COPD patients
Source: Annual Congress 2003 - Staging and outcome in COPD
Year: 2003


Respiratory system impedance with impulse oscillometry in Parkinson’s disease: Relation with disease severity
Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2016

COPD: CardiOPulmonary Disease?
Source: Eur Respir J 2013; 41: 1241-1243
Year: 2013


The metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Frequency of depression in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014

Case-finding options for COPD: results from the Burden of Obstructive Lung Disease Study
Source: Eur Respir J 2013; 41: 548-555
Year: 2013



The effect of comorbid Metabolic Syndrome and latent Obstructive Sleep Apnoea on the baseline medical parameters of volunteers screened from a Barrett's Esophagus Registry.
Source: International Congress 2018 – Innovations in equipment and their application
Year: 2018

Chronic obstructive pulmonary disease (COPD) and alterations of hemogram
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014

High prevalence of undiagnosed airflow obstruction in patients with ischaemic heart disease
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014

Thoracic determination of Behçet's disease
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Nasal inspiratory peak flow in sicke cell disease
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015


Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Obstructive sleep apnoea and cognitive decline in mild-to-moderate Alzheimer's disease
Source: Eur Respir J, 56 (5) 2000523; 10.1183/13993003.00523-2020
Year: 2020



Respiratory decline is integral to disease progression in Huntington's disease
Source: Eur Respir J 2016; 48: 585-588
Year: 2016


Incident Depression in Patients with Chronic Obstructive Pulmonary Disease: a UK Population-based Study
Source: Virtual Congress 2020 – Novelties in pulmonary rehabilitation and chronic respiratory care
Year: 2020